Endometriosis

• CLINICAL_TRIALS trial_result · 2008-01-25
  Clinical Trial Update: Acupuncture for Women's Health Conditions [Phase 1]

  Phase 1 clinical trial update on acupuncture for women's health conditions has completed the study.

• CLINICAL_TRIALS trial_result · 2008-01-25
  Clinical Trial Update: Endometriosis : Traditional Medicine vs Hormone Therapy [Phase 1, Phase 2]

  A completed Phase 1/2 clinical trial evaluated traditional medicine versus hormone therapy for endometriosis-related pelvic pain.

• CLINICAL_TRIALS trial_result · 2007-12-10
  Clinical Trial Update: Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women [Phase 2]

  Phase 2 trial update reporting safety and efficacy results for ERB-041 in reducing endometriosis-related symptoms in reproductive-aged women…

• FDA approval · 2007-11-08
  FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)

  FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA PHARMACEUTICALS, INC., signaling an expanded/updated …

• CLINICAL_TRIALS trial_result · 2007-04-23
  Clinical Trial Update: Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis [Phase 4]

  Phase 4 trial update on using Arimidex (anastrozole) and Zoladex (goserelin) as pretreatment before IVF in women with ovarian endometriosis.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-04-19
  FDA Approved: DANAZOL — Original Application (Lannett Company, Inc.)

  FDA approved the original application for the generic Danazol (DANAZOL) from Lannett Company, Inc. Indications include endometriosis, heredi…

• FDA approval · 2007-02-16
  FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)

  The FDA approved a supplemental application for TRELSTAR (triporelin pamoate) from Verity Pharmaceuticals Inc.